Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nuedexta for Episodic Migraine
NCT02176018Phase 2Completed
- Start
- Aug 2014
- Primary completion
- Feb 2017
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dextromethorphan + quinidine in episodic migraine. Started Aug 2014; status: completed.
02
Drugs
dextromethorphan + quinidine
03
Conditions
episodic migraine
Beyond the preview
Go deeper on NCT02176018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176018.